Ro 20-1724: An Agent that Significantly Improves Psoriatic Lesions in Double-Blind Clinical Trials

Overview of attention for article published in Journal of Investigative Dermatology, October 1979

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and…

Grant US-9468598-B2

United States of America

18 Oct 2016

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

Grant US-7960383-B2

United States of America

14 Jun 2011

Pyridazin-3(2H)-one derivatives

Grant US-7491722-B2

United States of America

17 Feb 2009

Pyridazin-3(2H)-one derivatives as PDE4 inhibitors

Grant US-7459453-B2

United States of America

02 Dec 2008

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.